A detailed history of Meridian Investment Counsel Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Meridian Investment Counsel Inc. holds 12,637 shares of MDT stock, worth $1.02 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
12,637
Previous 4,689 169.5%
Holding current value
$1.02 Million
Previous $369,000 208.13%
% of portfolio
0.35%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.84 - $91.03 $610,724 - $723,506
7,948 Added 169.5%
12,637 $1.14 Million
Q1 2024

May 13, 2024

SELL
$82.84 - $88.09 $1,656 - $1,761
-20 Reduced 0.42%
4,689 $408,000
Q3 2023

Nov 03, 2023

BUY
$78.22 - $90.4 $1,486 - $1,717
19 Added 0.41%
4,709 $368,000
Q2 2023

Aug 09, 2023

SELL
$79.47 - $91.38 $13,271 - $15,260
-167 Reduced 3.44%
4,690 $413,000
Q4 2022

Feb 06, 2023

BUY
$76.18 - $87.74 $25,063 - $28,866
329 Added 7.27%
4,857 $377,000
Q3 2022

Nov 08, 2022

BUY
$80.75 - $95.31 $2,018 - $2,382
25 Added 0.56%
4,528 $366,000
Q3 2021

Oct 27, 2021

SELL
$122.75 - $135.17 $8,715 - $9,597
-71 Reduced 1.55%
4,503 $564,000
Q2 2021

Jul 23, 2021

SELL
$118.19 - $131.5 $8,391 - $9,336
-71 Reduced 1.53%
4,574 $568,000
Q4 2020

Feb 03, 2021

SELL
$100.57 - $117.14 $48,072 - $55,992
-478 Reduced 9.33%
4,645 $544,000
Q2 2019

Aug 13, 2019

BUY
$84.15 - $99.38 $1,683 - $1,987
20 Added 0.39%
5,123 $499,000
Q1 2018

May 14, 2018

SELL
$76.55 - $87.26 $34,677 - $39,528
-453 Reduced 8.15%
5,103 $409,000
Q4 2017

Feb 13, 2018

SELL
$76.93 - $83.5 $7,693 - $8,350
-100 Reduced 1.77%
5,556 $449,000
Q3 2017

Nov 08, 2017

BUY
$77.71 - $84.6 $10,490 - $11,421
135 Added 2.45%
5,656 $440,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,521
5,521 $490,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Meridian Investment Counsel Inc. Portfolio

Follow Meridian Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meridian Investment Counsel Inc. with notifications on news.